SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-18-053549
Filing Date
2018-08-24
Accepted
2018-08-24 17:01:06
Documents
3
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a18-21011_210qa.htm 10-Q/A 56722
2 EX-31.1 a18-21011_2ex31d1.htm EX-31.1 12013
3 EX-31.2 a18-21011_2ex31d2.htm EX-31.2 11997
  Complete submission text file 0001104659-18-053549.txt   81846
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37813 | Film No.: 181037586
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences